ideology-health
  • Our Solutions
  • About Us
    • ideology-health
    Privacy Policy
    Terms of Service

    IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

    © 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.

    K

    Dr Katy Beckermann, MD

    Medical professional dedicated to sharing knowledge and insights through educational videos.

    Dr. Katy Beckermann describes the safety of erdafitinib and practical strategies for managing patients with FGFR-mutated mUC (Video 3/3)

    Dr. Katy Beckermann describes the safety of erdafitinib and practical strategies for managing patients with FGFR-mutated mUC (Video 3/3)

    THOR Safety

    Katy Beckermann, MD
    GU Cancers
    Dr. Katy Beckermann reviews the efficacy of erdafitinib in patients with FGFR-mutated mUC (Video 2/3)

    Dr. Katy Beckermann reviews the efficacy of erdafitinib in patients with FGFR-mutated mUC (Video 2/3)

    THOR Efficacy

    Katy Beckermann, MD
    GU Cancers
    Dr. Katy Beckermann discusses the importance of genetic testing in mUC (Video 1/3)

    Dr. Katy Beckermann discusses the importance of genetic testing in mUC (Video 1/3)

    THOR Testing

    Katy Beckermann, MD
    GU Cancers